These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 18277147)

  • 1. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome.
    Nair R; Fraer M; Agrawal N; Suneja M
    Transplant Proc; 2010 Nov; 42(9):3507-12. PubMed ID: 21094805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation.
    Toresan R; Manfro RC; Proença MC; Veronese FJ; Salim PH; da Silva DM; Ribeiro AR; Edelweiss MI; Pegas KL; Jobim LF
    Transplant Proc; 2008 Apr; 40(3):718-9. PubMed ID: 18454996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies.
    Serón D; Arns W; Chapman JR
    Nephrol Dial Transplant; 2008 Aug; 23(8):2467-73. PubMed ID: 18385386
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
    Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
    Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our evolving understanding of late kidney allograft failure.
    Gaston RS
    Curr Opin Organ Transplant; 2011 Dec; 16(6):594-9. PubMed ID: 21971511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic allograft nephropathy.
    Pietrzyk M; Hoffmann U; Krämer BK
    N Engl J Med; 2004 Mar; 350(12):1254-6; author reply 1254-6. PubMed ID: 15031859
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenesis of chronic renal allograft dysfunction].
    Morozumi K; Takeda A; Uchida K
    Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol transplant biopsies: are they really needed?
    Wilkinson A
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):130-7. PubMed ID: 17699199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
    Danger R; Giral M; Soulillou JP; Brouard S
    Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-toxicity immunosuppressive therapy in renal transplant].
    Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of living kidney transplantation from HLA-identical sibling donors under calcineurin inhibitor immunosuppression.
    Shimmura H; Tanabe K; Ishida H; Miyamoto N; Tokumoto T; Ishikawa N; Toma H
    Int J Urol; 2006 May; 13(5):502-8. PubMed ID: 16771716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical renal transplantation: where are we now, what are our key challenges?
    Chapman JR
    Transplant Proc; 2010 Nov; 42(9 Suppl):S3-6. PubMed ID: 21095448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.